Výsledky vyhledávání - "Tawassal Riaz"

Akademický článek

Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case–control studyResearch in context

Autor: Anastasia Chatzilena, Catherine Hyams, Rob Challen, Robin Marlow, Jade King, David Adegbite, Jane Kinney, Madeleine Clout, Nick Maskell, Jennifer Oliver, Leon Danon, Adam Finn, Anna Morley, Amelia Langdon, Anabella Turner, Anya Mattocks, Bethany Osborne, Charli Grimes, Claire Mitchell, Emma Bridgeman, Emma Scott, Fiona Perkins, Francesca Bayley, Gabriella Ruffino, Gabriella Valentine, Grace Tilzey, Johanna Kellett Wright, Julia Brzezinska, Julie Cloake, Katarina Milutinovic, Kate Helliker, Katie Maughan, Kazminder Fox, Konstantina Minou, Lana Ward, Leah Fleming, Leigh Morrison, Lily Smart, Louise Wright, Lucy Grimwood, Maddalena Bellavia, Marianne Vasquez, Maria Garcia Gonzalez, Milo Jeenes-Flanagan, Natalie Chang, Niall Grace, Nicola Manning, Oliver Griffiths, Pip Croxford, Peter Sequenza, Rajeka Lazarus, Rhian Walters, Robyn Heath, Rupert Antico, Sandi Nammuni Arachchge, Seevakumar Suppiah, Taslima Mona, Tawassal Riaz, Vicki Mackay, Zandile Maseko, Zoe Taylor, Zsolt Friedrich, Zsuzsa Szasz-Benczur

Publikováno v: The Lancet Regional Health. Europe, Vol 25, Iss , Pp 100552- (2023)

Summary: Background: Whilst other studies have reported the effectiveness of mRNA vaccination against hospitalisation, including emergency department or intensive care admission, few have assessed effectiveness against other more clinically robust in

Externí odkaz: https://doaj.org/article/bd097d394c5b4248aa183ae8c78fd285

Zobrazit plný text záznamu

Akademický článek

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomResearch in context

Autor: Catherine Hyams, Robert Challen, Robin Marlow, Jennifer Nguyen, Elizabeth Begier, Jo Southern, Jade King, Anna Morley, Jane Kinney, Madeleine Clout, Jennifer Oliver, Sharon Gray, Gillian Ellsbury, Nick Maskell, Luis Jodar, Bradford Gessner, John McLaughlin, Leon Danon, Adam Finn, Amelia Langdon, Anabella Turner, Anya Mattocks, Bethany Osborne, Charli Grimes, Claire Mitchell, David Adegbite, Emma Bridgeman, Emma Scott, Fiona Perkins, Francesca Bayley, Gabriella Ruffino, Gabriella Valentine, Grace Tilzey, James Campling, Johanna Kellett Wright, Julia Brzezinska, Julie Cloake, Katarina Milutinovic, Kate Helliker, Katie Maughan, Kazminder Fox, Konstantina Minou, Lana Ward, Leah Fleming, Leigh Morrison, Lily Smart, Louise Wright, Lucy Grimwood, Maddalena Bellavia, Marianne Vasquez, Maria Garcia Gonzalez, Milo Jeenes-Flanagan, Natalie Chang, Niall Grace, Nicola Manning, Oliver Griffiths, Pip Croxford, Peter Sequenza, Rajeka Lazarus, Rhian Walters, Robyn Heath, Rupert Antico, Sandi Nammuni Arachchge, Seevakumar Suppiah, Taslima Mona, Tawassal Riaz, Vicki Mackay, Zandile Maseko, Zoe Taylor, Zsolt Friedrich, Zsuzsa Szasz-Benczur

Publikováno v: The Lancet Regional Health. Europe, Vol 25, Iss , Pp 100556- (2023)

Summary: Background: There is an urgent public health need to evaluate disease severity in adults hospitalised with Delta and Omicron SARS-CoV-2 variant infections. However, limited data exist assessing severity of disease in adults hospitalised with

Externí odkaz: https://doaj.org/article/48870e4442ed4c979d2bf5a82bb8cc0e

Zobrazit plný text záznamu

Akademický článek

Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study

Autor: Catherine Hyams, Robert Challen, Elizabeth Begier, Jo Southern, Jade King, Anna Morley, Zsuzsa Szasz-Benczur, Maria Garcia Gonzalez, Jane Kinney, James Campling, Sharon Gray, Jennifer Oliver, Robin Hubler, Srinivas Valluri, Andrew Vyse, John M. McLaughlin, Gillian Ellsbury, Nick A. Maskell, Bradford D. Gessner, Leon Danon, Adam Finn, Amelia Langdon, Anabella Turner, Anya Mattocks, Bethany Osborne, Charli Grimes, Claire Mitchell, David Adegbite, Emma Bridgeman, Emma Scott, Fiona Perkins, Francesca Bayley, Gabriella Ruffino, Gabriella Valentine, Grace Tilzey, Johanna Kellett Wright, Julia Brzezinska, Julie Cloake, Katarina Milutinovic, Kate Helliker, Katie Maughan, Kazminder Fox, Konstantina Minou, Lana Ward, Leah Fleming, Leigh Morrison, Lily Smart, Louise Wright, Lucy Grimwood, Maddalena Bellavia, Madeleine Clout, Marianne Vasquez, Milo Jeenes-Flanagan, Natalie Chang, Niall Grace, Nicola Manning, Oliver Griffiths, Pip Croxford, Peter Sequenza, Rajeka Lazarus, Rhian Walters, Robin Marlow, Robyn Heath, Rupert Antico, Sandi Nammuni Arachchge, Seevakumar Suppiah, Taslima Mona, Tawassal Riaz, Vicki Mackay, Zandile Maseko, Zoe Taylor, Zsolt Friedrich

Publikováno v: The Lancet Regional Health. Europe, Vol 21, Iss , Pp 100473- (2022)

Summary: Background: The emergence of COVID-19 and public health measures implemented to reduce SARS-CoV-2 infections have both affected acute lower respiratory tract disease (aLRTD) epidemiology and incidence trends. The severity of COVID-19 and non

Externí odkaz: https://doaj.org/article/2dc6ac7e11b84a43aec5b94d55c81b3f

Zobrazit plný text záznamu

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults:A prospective cohort study in Bristol, United Kingdom

Publikováno v: Hyams, C, Challen, R, Marlow, R, Nguyen, J, Begier, E, Southern, J, King, J, Morley, A, Kinney, J, Oliver, J, Gray, S, Ellsbury, G, Maskell, N, Jodar, L, Gessner, B, McLaughlin, J & Danon, L & Finn, A 2023, ' Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults : A prospective cohort study in Bristol, United Kingdom ', The Lancet Regional Health-Europe, vol. 25, 100556 . https://doi.org/10.1016/j.lanepe.2022.100556

BACKGROUND: There is an urgent public health need to evaluate disease severity in adults hospitalised with Delta and Omicron SARS-CoV-2 variant infections. However, limited data exist assessing severity of disease in adults hospitalised with Omicron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5758d74ec9a9eebdc8c86b48409402b
https://research-information.bris.ac.uk/en/publications/e2ed4210-5c81-4a6b-88da-b68a74bc3ca3

Zobrazit plný text záznamu

Publikováno v: 2023, ' Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022 : A prospective test negative case-control study ', The Lancet Regional Health-Europe, vol. 25, 100552, pp. 1-13 . https://doi.org/10.1016/j.lanepe.2022.100552, https://doi.org/10.1016/j.lanepe.2022.100552

BACKGROUND: Whilst other studies have reported the effectiveness of mRNA vaccination against hospitalisation, including emergency department or intensive care admission, few have assessed effectiveness against other more clinically robust indices of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec3b96bf3fe67ea18f884cbf94fea5e
https://research-information.bris.ac.uk/ws/files/349283926/1_s2.0_S2666776222002484_main.pdf

Zobrazit plný text záznamu

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

Autor: Robert H Shaw, Xinxue Liu, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, J Claire Cameron, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins, Wanwisa Dejnirattisai, Tanya Dinesh, Saul N Faust, Daniela M Ferreira, Adam Finn, Christopher A Green, Bassam Hallis, Paul T Heath, Helen Hill, Teresa Lambe, Rajeka Lazarus, Vincenzo Libri, Fei Long, Yama F Mujadidi, Emma L Plested, Ella R Morey, Samuel Provstgaard-Morys, Maheshi N Ramasamy, Mary Ramsay, Robert C Read, Hannah Robinson, Gavin R Screaton, Nisha Singh, David P J Turner, Paul J Turner, Iason Vichos, Laura L Walker, Rachel White, Jonathan S Nguyen-Van-Tam, Matthew D Snape, Alasdair P.S. Munro, Jazz Bartholomew, Laura Presland, Sarah Horswill, Sarah Warren, Sophie Varkonyi-Clifford, Stephen Saich, Kirsty Adams, Marivic Ricamara, Nicola Turner, Nicole Y. Yee Ting, Sarah Whittley, Tommy Rampling, Amisha Desai, Claire H. Brown, Ehsaan Qureshi, Karishma Gokani, Kush Naker, Johanna K. Kellett Wright, Rachel L. Williams, Tawassal Riaz, Florentina D. Penciu, Amy Carson, Claudio Di Maso, Gracie Mead, Elizabeth G. Howe, Mujtaba Ghulam Farooq, Rabiullah Noristani, Xin L. Yao, Neil J. Oldfield, Daniel Hammersley, Sue Belton, Simon Royal, Alberto San Francisco Ramos, Cecilia Hultin, Eva P. Galiza, Rebecca Crook, Marcin Bula, Fred Fyles, Hassan Burhan, Flora Maelin, Elen Hughes, Emmanuel Okenyi

Publikováno v: Shaw, R H, Liu, X, Stuart, A S V, Greenland, M, Aley, P K, Andrews, N J, Finn, A & Lazarus, R & et, A 2022, ' Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules : exploratory analyses of Com-COV, a randomised control trial ', Lancet Respiratory Medicine, vol. 10, no. 11, pp. 1049-1060 . https://doi.org/10.1016/S2213-2600(22)00163-1

Background Priming COVID-19 vaccine schedules have been deployed at variable intervals globally, which might influence immune persistence and the relative importance of third-dose booster programmes. Here, we report exploratory analyses from the Com-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed4ea510bf1be44fbc2afbfb9cf0590
https://eprints.soton.ac.uk/456454/

Zobrazit plný text záznamu

Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001:A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults

Publikováno v: Lazarus, R, Taucher, C, Brown, C, Čorbic Ramljak, I, Danon, L, Dubischar, K, Duncan, C J A, Wright, J K, Kwon, D, Middleditch, A, Penciu, F & Riaz, T & Finn, A 2022, ' Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001 : A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults ', Journal of Infection, vol. 85, no. 3, pp. 306-317 . https://doi.org/10.1016/j.jinf.2022.06.009

ObjectivesWe aimed to evaluate the safety and optimal dose of a novel inactivated whole-virus adjuvanted vaccine against SARS-CoV-2: VLA2001.MethodsWe conducted an open-label, dose-escalation study followed by a double-blind randomized trial using lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6d92d36d7339c943254c66dc4f01b8
https://research-information.bris.ac.uk/ws/files/326370279/220603_Submission_YJINF_S_22_01769.pdf

Zobrazit plný text záznamu

Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration

Autor: Rachel L. Williams, Catherine Hyams, Joe Robertshaw, Maria Garcia Gonzalez, Zsuzsa Szasz-Benczur, Paul White, Nick A. Maskell, Adam Finn, Shaney L. Barratt, David Adegbite, Rupert Antico, Francesca Bayley, Beth Begier, Maddalena Bellavia, Emma Bridgeman, Julia Brzezinska, James Campling, Natalie Chang, Julie Cloake, Madeleine Clout, Pip Croxford, Gillian Ellsbury, Bradford Gessner, Niall Grace, Sharon Gray, Oliver Griffiths, Charli Grimes, Lucy Grimwood, Zsolt Friedrich, Leah Fleming, Kazminder Fox, Milo Jeenes-Flanagan, Luis Jodar, Johanna Kellett Wright, Jane Kinney, Robyn Heath, Kate Helliker, Robyn Huber, Amelia Langdon, Rajeka Lazarus, Sandi Nammuni Arachchge, Vicki Mackay, Robin Marlow, Zandile Maseko, Anya Mattocks, Katie Maughan, Nicola Manning, Katarina Milutinovic, Konstantina Minou, Anna Morley, Taslima Mona, Claire Mitchell, Leigh Morrison, Bethany Osborne, Fiona Perkins, Tawassal Riaz, Gabriella Ruffino, Peter Sequenza, Lily Smart, Emma Scott, Jo Southern, Seevakumar Suppiah, Zoe Taylor, Grace Tilzey, Anabella Turner, Gabriella Valentine, Marianne Vasquez, Rhian Walters, Lana Ward, Louise Wright

Publikováno v: Respiratory Medicine. 212:107220

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a0366a3a073a7615533ea28c256fc5c
https://doi.org/10.1016/j.rmed.2023.107220

Zobrazit plný text záznamu

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Autor: Sophie Varkonyi-Clifford, Sue Charlton, Anna England, Matthew D. Snape, Parvinder K. Aley, Elizabeth A. Clutterbuck, Pauline Ambrose, Eva P. Galiza, Adam Finn, Laura L. Walker, Emma Plested, Ehsaan Qureshi, Chanice Knight, David P. J. Turner, Lisa Hitchins, Mujtaba Ghulam Farooq, Christopher A Green, Melanie Greenland, J. Claire Cameron, Stephanie Leung, Karen Buttigieg, Jonathan S. Nguyen-Van-Tam, Cecilia Hultin, Florentina D Penciu, Jazz Bartholomew, Yama F Mujadidi, Nisha Singh, Sarah Horswill, Tommy Rampling, Kush Naker, Rabiullah Noristani, Xinxue Liu, Marivic Ricamara, Tawassal Riaz, Phill Brown, Rajeka Lazarus, Imam Shaik, Johanna K Kellett Wright, Kerry Godwin, Kelly Davies, Robert Shaw, Paminder Lall, Neil J. Oldfield, Farah Shiham, Sue Belton, Karishma Gokani, Carla Solórzano, Mary Ramsay, Kirsty Adams, Ross Fothergill, Hannah Robinson, Claudio Di Maso, Rachel Williams, Lauren Allen, Paul T. Heath, Sarah Whittley, Stephen Saich, E Howe, Bassam Hallis, Alberto San Francisco Ramos, Simon Royal, Alasdair Munro, Tanya Dinesh, Vincenzo Libri, Helen Hill, Arabella Stuart, Samuel Provstgaard-Morys, Xin L Yao, Andrea M. Collins, Rachel White, Paul Turner, Teresa Lambe, Nick Andrews, Iason Vichos, Daniela M. Ferreira, Natalie Baker, Nicole Y Yee Ting, Claire Brown, M N Ramasamy, Sarah Warren, Amisha Desai, Fei Long, Laura Presland, Hannah Sainsbury, Daniel Hammersley, Saul N. Faust, Robert C. Read, Nicola Turner

Publikováno v: Lancet (London, England)
Snape, M D 2021, ' Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial ', Lancet, vol. 398, no. 10303, pp. 856-869 . https://doi.org/10.1016/S0140-6736(21)01694-9

Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate mass COVID-19 immunisation. However, we have previously reported that heterologous schedules incorporating an adenoviral vectored vaccine (ChAdOx1 nCoV-19, AstraZe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7eb0c3096b9959acb86f69d3e95e02b
https://pubmed.ncbi.nlm.nih.gov/34370969

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání